Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Frontiers in Toxicology
|
May 22, 2023
Development of a bioprinter-based method for incorporating metabolic competence into high-throughput <i>in vitro</i> assays
Kristen Hopperstad, Chad Deisenroth
Genes & Cancer
|
July 23, 2011
The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine
Chad Deisenroth, Yanping Zhang
Current Research in Toxicology
|
February 28, 2025
Profiling assay performance in the DevTox germ layer reporter platform
John T Gamble, Chad Deisenroth
Trends in Cancer
|
July 26, 2017
RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
Yong Liu, Chad Deisenroth, Yanping Zhang
Cold Spring Harbor Perspectives in Medicine
|
December 3, 2016
The Evolution of the Ribosomal Protein-MDM2-p53 Pathway
Chad Deisenroth, Derek A Franklin, Yanping Zhang
Cell Cycle (Georgetown, Tex.)
|
March 3, 2007
Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions
Mikael S Lindström, Chad Deisenroth, Yanping Zhang
Toxics
|
July 25, 2022
The DevTox Germ Layer Reporter Platform: An Assay Adaptation of the Human Pluripotent Stem Cell Test
John T Gamble, Kristen Hopperstad, Chad Deisenroth
The Journal of Biological Chemistry
|
June 11, 2011
p53-Inducible DHRS3 is an endoplasmic reticulum protein associated with lipid droplet accumulation
Chad Deisenroth, Yoko Itahana, Laura Tollini, et al.
Molecular and Cellular Biology
|
June 16, 2010
Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53
Chad Deisenroth, Aaron R Thorner, Takeharu Enomoto, et al.
Molecular and Cellular Biology
|
November 23, 2006
Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation
Mikael S Lindström, Aiwen Jin, Chad Deisenroth, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Frontiers in Toxicology
|
May 22, 2023
Development of a bioprinter-based method for incorporating metabolic competence into high-throughput <i>in vitro</i> assays
Kristen Hopperstad, Chad Deisenroth
Genes & Cancer
|
July 23, 2011
The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine
Chad Deisenroth, Yanping Zhang
Current Research in Toxicology
|
February 28, 2025
Profiling assay performance in the DevTox germ layer reporter platform
John T Gamble, Chad Deisenroth
Trends in Cancer
|
July 26, 2017
RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
Yong Liu, Chad Deisenroth, Yanping Zhang
Cold Spring Harbor Perspectives in Medicine
|
December 3, 2016
The Evolution of the Ribosomal Protein-MDM2-p53 Pathway
Chad Deisenroth, Derek A Franklin, Yanping Zhang
Cell Cycle (Georgetown, Tex.)
|
March 3, 2007
Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions
Mikael S Lindström, Chad Deisenroth, Yanping Zhang
Toxics
|
July 25, 2022
The DevTox Germ Layer Reporter Platform: An Assay Adaptation of the Human Pluripotent Stem Cell Test
John T Gamble, Kristen Hopperstad, Chad Deisenroth
The Journal of Biological Chemistry
|
June 11, 2011
p53-Inducible DHRS3 is an endoplasmic reticulum protein associated with lipid droplet accumulation
Chad Deisenroth, Yoko Itahana, Laura Tollini, et al.
Molecular and Cellular Biology
|
June 16, 2010
Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53
Chad Deisenroth, Aaron R Thorner, Takeharu Enomoto, et al.
Molecular and Cellular Biology
|
November 23, 2006
Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation
Mikael S Lindström, Aiwen Jin, Chad Deisenroth, et al.
Page
of 4